Clinigene, Pacific Biomarkers collaborate
Clinigene International and Pacific Biomarkers have formed a collaborative agreement to address the specialty biomarker and high-end clinical trial laboratory needs of the global pharmaceutical and biotechnology industry.
Clinigene, is an India-based clinical research organization that offers end-to-end clinical and laboratory services for accelerating clinical research, and Pacific Biomarkers, is a Seattle, WA-based company that provides premier biomarker and specialty efficacy testing services to the drug development industry.
“This partnership with Clinigene provides us access to India, an emerging hub for drug development and contract research. Further, Clinigene’s state-of-the-art facilities and highly qualified staff help us offer to all of our clients an economic option to conduct their biomarker and specialty clinical lab tests. We are also excited about Clinigene’ s unique capabilities in cell-based assays and immunoanalytical testing services, which are of great interest to the global pharmaceutical and biotechnology community,” said Ronald Helm, CEO of Pacific Biomarkers.